Oxford BioDynamics Plc (AIM:OBD)

Market Cap	7.61M
Revenue (ttm)	636.00K
Net Income (ttm)	-11.57M
Shares Out	1.96B
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,990,796
Average Volume	6,971,848
Open	0.3930
Previous Close	0.3750
Day's Range	0.3500 - 0.4000
52-Week Range	0.3000 - 8.4000
Beta	-0.16
RSI	44.14
Earnings Date	Jun 20, 2025

About Oxford BioDynamics

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibito...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 51
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: OBD

Financial Performance

In 2024, Oxford BioDynamics's revenue was 636,000, an increase of 24.71% compared to the previous year's 510,000. Losses were -11.57 million, 6.84% more than in 2023.